| (Values in U.S. Thousands) | Mar, 2025 | Dec, 2024 | Sep, 2024 | Jun, 2024 | Mar, 2024 |
| Sales | 3,170 | 2,820 | 1,200 | 30 | 10 |
| Sales Growth | +12.41% | +135.00% | +3,900.00% | +200.00% | -90.91% |
| Net Income | -620 | -6,780 | -1,960 | -2,170 | -1,500 |
| Net Income Growth | +90.86% | -245.92% | +9.68% | -44.67% | +61.14% |
Foxo Technologies Inc (FOXO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
FOXO Technologies Inc. is a technology platform company whose products and services seek to address long-standing, core problems within the life insurance industry through epigenetic longevity science. FOXO Technologies Inc., formerly known as Delwinds Insurance Acquisition Corp., is based in MINNEAPOLIS.
Fiscal Year End Date: 12/31